Google Cloud Launches AI Tools To Speed Up Drug Development Process | High Times Total 0 Share Read more
Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK, May 17, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”),... Read more
AYR Wellness Reports First Quarter 2023 Results Excluding Discontinued Operations, Revenue up 18% Y/Y to $117.7 Million, up 3% sequentially Excluding Discontinued Operations, Adjusted EBITDA1 up 64% Y/Y to $26.3 Million, up 9% sequentially (GAAP loss from operations was $21.7 Million, compared to $21.0 Million in Q1/22) Q1 Ending Cash... Read more
Nashville Jams With THC Seltzer | High Times Total 0 Share Read more
Salem, Massachusetts Will No Longer Arrest People for Psilocybin | High Times Total 0 Share Read more
Washington Governor Signs Bill to Protect Employees from Drug Testing for THC | High Times Total 0 Share Read more
Switzerland Continues to Expand Cannabis Research Trials | High Times Total 0 Share Read more
Ban on Outdoor Pot Smoking in Amsterdam’s Red Light District To Begin This Month | High Times Total 0 Share Read more
Glass House Brands Reports First Quarter 2023 Financial Results Achieved Positive Free Cash Flow1 Narrowed Adjusted EBITDA2 loss to $0.1 million versus $2.6 million loss in Q4 Revenue of $29.0M, up 108% from Q1 2022 Gross margin of 41% versus 32% in Q4 2022 and 17% in the prior year period Q1 Biomass production3 up 188%... Read more
Greenlane Reports Q1 2023 Revenue Increase of 9% and a 32% Decrease in Operating Expenses Over Q4 2022 BOCA RATON, FL / ACCESSWIRE / May 15, 2023 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )